Other:

Gerhard Zbinden

The Significance of Pharmacologic Screening Tests in the Preclinical Safety Evalution of New Drugs
J New Drugs 1966 6: 1. [PDF]  

Jan W. Kuzma

Some Problems in the Evaluation of Tumor Responses in the Clinical Drug Evaluation Program
J New Drugs 1966 6: 8. [PDF]  

Henry B. Murphree

Methodology for the Clinical Evaluation of Analgesics
J New Drugs 1966 6: 15. [PDF]  

Seymour B. Bronstein

Aspects of the Clinical Evaluation of Female Sex Hormones
J New Drugs 1966 6: 23. [PDF]  

Albert Cohen, Donald A. Corgill, William Abruzzi, C. Wayne Ligon, and Eugene A. DeFelice

Double-Blind Comparison of Namoxyrate and d-Propoxyphene: A Cooperative Clinical Trial
J New Drugs 1966 6: 38. [PDF]  

May G. Wilson and Wan Ngo Lim

Evaluation of Steroid Therapy for Active Carditis: Follow-Up of 1 to 14 Years
J New Drugs 1966 6: 45. [PDF]  

Sylvia Rapp and Charles H. Carter

Use of a Polygraph to Measure Spastic Activity in Athetoid Patients
J New Drugs 1966 6: 49. [PDF]  

Christopher E. Ramethan, Allan E. Edwards, and Sidney Cohen

The Effect of Bamethan on Cardiovascular Response
J New Drugs 1966 6: 55. [PDF]  

Ralph G. Smith

How Safe are Drugs?: The Viewpoint of the Food and Drug Administration
J New Drugs 1966 6: 62. [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.